PMC:7074424 / 8011-8498 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"158","span":{"begin":37,"end":40},"obj":"Species"},{"id":"171","span":{"begin":122,"end":125},"obj":"Species"},{"id":"172","span":{"begin":322,"end":331},"obj":"Chemical"},{"id":"173","span":{"begin":357,"end":374},"obj":"Chemical"},{"id":"174","span":{"begin":453,"end":462},"obj":"Chemical"},{"id":"175","span":{"begin":470,"end":479},"obj":"Chemical"}],"attributes":[{"id":"A158","pred":"tao:has_database_id","subj":"158","obj":"Tax:11118"},{"id":"A171","pred":"tao:has_database_id","subj":"171","obj":"Tax:11118"},{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"MESH:D012254"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"MESH:D009173"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"MESH:D019438"},{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"MESH:D061466"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}

{"project":"2_test","denotations":[{"id":"32201449-24564608-47217021","span":{"begin":237,"end":239},"obj":"24564608"},{"id":"32201449-25614110-47217022","span":{"begin":237,"end":241},"obj":"25614110"},{"id":"32201449-28794876-47217023","span":{"begin":376,"end":377},"obj":"28794876"},{"id":"T67848","span":{"begin":237,"end":239},"obj":"24564608"},{"id":"T5665","span":{"begin":237,"end":241},"obj":"25614110"},{"id":"T88783","span":{"begin":376,"end":377},"obj":"28794876"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T929","span":{"begin":12,"end":15},"obj":"SO:0000236"},{"id":"T928","span":{"begin":17,"end":35},"obj":"SO:0000236"},{"id":"T927","span":{"begin":42,"end":53},"obj":"NCBITaxon:11118"},{"id":"T177","span":{"begin":96,"end":100},"obj":"CHEBI:36044;CHEBI:36044"},{"id":"T176","span":{"begin":248,"end":266},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T175","span":{"begin":322,"end":331},"obj":"CHEBI:28201;CHEBI:28201;DG_29"},{"id":"T174","span":{"begin":357,"end":374},"obj":"CHEBI:168396;CHEBI:168396"},{"id":"T173","span":{"begin":437,"end":441},"obj":"CHEBI:35472;CHEBI:35472"},{"id":"T172","span":{"begin":441,"end":442},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T171","span":{"begin":442,"end":445},"obj":"CHEBI:35472;CHEBI:35472"},{"id":"T170","span":{"begin":446,"end":451},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T169","span":{"begin":453,"end":462},"obj":"CHEBI:45409;CHEBI:45409;DG_30"},{"id":"T168","span":{"begin":470,"end":479},"obj":"CHEBI:31781;CHEBI:31781;DG_23"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T93","span":{"begin":442,"end":445},"obj":"Body_part"}],"attributes":[{"id":"A93","pred":"fma_id","subj":"T93","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T87","span":{"begin":176,"end":181},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"},{"id":"T88","span":{"begin":312,"end":317},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52","span":{"begin":86,"end":100},"obj":"Chemical"},{"id":"T53","span":{"begin":86,"end":95},"obj":"Chemical"},{"id":"T54","span":{"begin":96,"end":100},"obj":"Chemical"},{"id":"T55","span":{"begin":312,"end":317},"obj":"Chemical"},{"id":"T56","span":{"begin":322,"end":331},"obj":"Chemical"},{"id":"T57","span":{"begin":333,"end":343},"obj":"Chemical"},{"id":"T58","span":{"begin":345,"end":348},"obj":"Chemical"},{"id":"T59","span":{"begin":357,"end":374},"obj":"Chemical"},{"id":"T60","span":{"begin":370,"end":374},"obj":"Chemical"},{"id":"T61","span":{"begin":446,"end":451},"obj":"Chemical"},{"id":"T62","span":{"begin":453,"end":462},"obj":"Chemical"},{"id":"T63","span":{"begin":470,"end":479},"obj":"Chemical"}],"attributes":[{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A59","pred":"chebi_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/CHEBI_168396"},{"id":"A60","pred":"chebi_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A61","pred":"chebi_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A63","pred":"chebi_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}

{"project":"LitCovid-sentences","denotations":[{"id":"T38","span":{"begin":17,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"lyproteins, ORF: Open reading frame, CoV: coronavirus Currently, there is no specific antiviral drug for the treatment of CoV-associated pathologies. Most treatment strategies focus on symptomatic management and supportive therapy only.[2627] Some therapeutic agents that are under development or being used off-label are ribavirin, interferon (IFN)-α, and mycophenolic acid.[7] There are many newspaper articles citing effectiveness of anti-HIV drugs: ritonavir,[2829] lopinavir,[29] ei"}